Chinese Journal of Clinical Hepatology 2013 Issue 5 Diagnosis of hepatic fibrosis in hepatitis B patients by logistic regression modeling based on plasma amino acid ratio and age

Diagnosis of hepatic fibrosis in hepatitis B patients by logistic regression modeling based on plasma amino acid ratio and age
ZHANG Zhanqing;LU Wei;WANG Yanbing;et al.

..............page:330-335

Effects of liver inflammation on FibroScan diagnosis of hepatic fibrosis in patients with chronic hepatitis B
LIU Zhiquan;FENG Junhua;YE Lihong;et al.

..............page:336-338

Changes in serum complement components after 48 weeks of entecavir treatment in hepatitis B cirrhosis patients
ZHANG Xuehua;LI Zhongping.

..............page:339-342,347

Diagnostic value of the APRI index for liver fibrosis in a Chinese patients population with chronic hepatitis C acquired from blood transfusion
LEI Chengduo;REN Yan;ZHENG Sujun;et al.

..............page:343-347

Potential of G-CSF supplementation to counter the neutrophil effects of standard PEG-IFNα plus ribavirin combination therapy for treating HCV-related cirrhosis
ZHANG Sumei;XIE Yumei;ZHANG Ying;et al.

..............page:348-351

Survey of 2002 cases of liver cirrhosis: Identification of etiological factors and related complications
AI Min;CHEN Weichan;SHEN Wei.

..............page:352-355,362

Colonoscopy-based diagnosis of portal hypertensive colopathy in cirrhotic patients and relation to hepatic disease pathogenesis
CHEN Linyan;XIA Shihai;WANG Yulin;et al.

..............page:356-358

Low-/high-frequency ultrasound study of liver parenchyma morphology to determine diagnostic utility for extent of liver fibrosis in patients with chronic hepatitis
LIN Jianling.

..............page:359-362

Treatment of portal hypertension with combined vagus trunk-preserving portoazygous devascularization and shunting: Report of 28 cases
JIAN Yizeng;TONG Qingdong;YU Qiangfeng.

..............page:363-364,374

Efficacy of percutaneous transhepatic variceal embolization with 2-Octyl-cyanoacrylate in patients with severe recurrent hepatic encephalopathy
WANG Guangchuan;HU Jinhua;FENG Hua;et al.

..............page:365-369

IL-17 promotes expression of fibrosis-related factors in hepatic stellate cells
GUAN Haitao;ZHAO Jinli;TANG Rui;et al.

..............page:370-374

Role and molecular mechanism of HO-1-mediated NF-κB modulation in fibrosis progression of nonalcoholic steatohepatitis
NAN Yuemin;MI Hongmei;DU Jinghua;et al.

..............page:375-378

Investigation of CD4~+CXCR5~+ follicular helper T cell frequency and expression of related functional molecules in peripheral blood of hepatitis C virus patients
WANG Yu;MA Zhiyuan;GUO Yonghong;et al.

..............page:379-382

Case report of a 2-year misdiagnosis and mismanagement of liver cirrhosis complicated by POEMS syndrome
WANG Shanjuan;ZHANG Lihang;MAO Junling;et al.

..............page:383-384

lin chuang gan dan bing za zhi bei mei guo shi di fen si shu ju ku (ebscohost) quan wen shou lu

..............page:384

lin chuang gan dan bing za zhi 2013 nian 1 10 qi zhong dian hao xuan ti

..............page:384

Recent research on liver fibrosis and cirrhosis
LU Lungen;LI Zhenghong.

..............page:321-323

Recent perspectives on mechanisms of liver fibrogenesis: microRNA and cell autophagy
GUO Jinsheng.

..............page:324-326

Review and comparison of commonly used nutritional risk screening tools in patients with liver cirrhosis
ZHU Ming;XU Lieming.

..............page:327-329

guan yu xiong qu yang dan suan zao qi sheng hua ying da yu yuan fa xing dan zhi xing gan ying hua chang qi yu hou guan xi de 14 nian dui lie yan jiu
zeng xiang hua wang yu ming

..............page:326

yi xiang sui ji lin chuang shi yan : wan gu mei su huo jia xiao zuo zai yuan fa xing ying hua xing dan guan yan huan zhe zhong de shi yan xing yan jiu
ding sheng zuo

..............page:402

Recent progress in understanding the role of microRNAs in hepatic stellate cell biology and liver fibrosis pathogenesis
LI Binbin;MING Jian;CHEN Dagui;et al.

..............page:385-388

PI3K/Akt signaling pathway and hepatic fibrosis
PAN Peng;LIU Shaoneng.

..............page:389-392,396

Current perspectives on the JAK/STAT signaling pathway and its activating factors in liver fibrosis
PAN Jin;JU Jian.

..............page:393-396

Recent advances in understanding the relations between liver cirrhosis and sleep disorders
WU Jianjin;YAO Dingkang.

..............page:397-400

Key points of the AASLD′s guidelines on the management of acute liver failure
YAN Guohua;WANG Yuming.

..............page:401-402

Key points of the AASLD′s guidelines on hemochromatosis diagnosis and treatment
JIN Jinglan;ZHAO Xu;LI Guangming;et al.

..............page:403-405